tirzepatide hair loss studies and Loss: Causes, Clinical Evidence and What Really Helps with Mounjaro and Zepbound Does Tirzepatide Cause Hair Loss?

Exclusive Pharma Industry 4 min read After WHO nod, Indian Patient Groups urge GLP-1 inclusion in NLEM With the WHO recommending blockbuster GLP-1 therapies such as Semaglutide and Tirzepatide as essential medicines for diabetes, patient advocates in India are urging their inclusion in the National List of Essential Medicines (NLEM) to enable state procurement, free distribution, and wider affordability

For many people, the switch comes down to cost and coverage, not just which medication works better

Long-term and serious risks: what does science say

How tough the competition is in the GLP-1 market will also depend on the number of players in the first launch wave

Project administration YW, HW